| Literature DB >> 32614407 |
Zhiqiang Wen1, Sufang Zhang2, Chuks Kenneth Odoh2, Mingjie Jin1, Zongbao K Zhao2,3.
Abstract
The red yeast Rhodosporidium toruloides naturally produces microbial lipids and carotenoids. In the past decade or so, many studies demonstrated R. toruloides as a promising platform for lipid production owing to its diverse substrate appetites, robust stress resistance and other favorable features. Also, significant progresses have been made in genome sequencing, multi-omic analysis and genome-scale modeling, thus illuminating the molecular basis behind its physiology, metabolism and response to environmental stresses. At the same time, genetic parts and tools are continuously being developed to manipulate this distinctive organism. Engineered R. toruloides strains are emerging for enhanced production of conventional lipids, functional lipids as well as other interesting metabolites. This review updates those progresses and highlights future directions for advanced biotechnological applications. © FEMS 2020.Entities:
Keywords: zzm321990 Rhodosporidium toruloideszzm321990 ; chassis organism; genetic modification; microbial lipids; multi-omic analysis
Year: 2020 PMID: 32614407 PMCID: PMC7334043 DOI: 10.1093/femsyr/foaa038
Source DB: PubMed Journal: FEMS Yeast Res ISSN: 1567-1356 Impact factor: 2.796
Figure 1.Milestones of systems biology studies in genus Rhodosporidium. The publication year, strain name and research approach are listed. Different colors are shown for genomics, proteomics, transcriptomics, metabolomics and in-silico modeling.
Figure 2.The primary metabolic pathways of R. toruloides. Key genes involved in glycolysis, pentose phosphate pathway, TCA cycle in mitochondria, biosynthesis and degradation of fatty acids, triacylglycerols and phospholipids, isoprenoid biosynthesis, glyoxylate cycle pathway, and the β-oxidation pathways in peroxisomes are highlighted in green. Abbreviations: GA-3-P, glyceraldehyde 3-phosphate; DHA, dihydroxyacetone; DHAP, dihydroxyacetone phosphate; G-3-P, glycerol-3-phosphate; LPA, lysophosphatidic acid; PA, phosphatidic acid; DAG, diacylglycerol; TAG, triacylglycerol; SE, steryl ester; FFA, free fatty acid; OAA, oxaloacetate; AHG, α-ketoglutarate; AcAcCoA, aceto-acetyl-CoA; HMG-CoA, hydroxymethylglutaryl-CoA; MVA, mevalonate; MVA5P, mevalonate-5-phosphate; MVA5PP, mevalonate-5-diphosphate; IPP, isopentenyl diphosphate; DMAPP, dimethylallyl diphosphate; GPP, geranyl diphosphate; FPP, farnesyl diphosphate; GGPP, geranylgeranyl diphosphate; AMP, adenosine monophosphate; IMP, inosine monophosphate.
Figure 3.Strains engineering of genus Rhodosporidium as microbial platform. With the aid of rational and semi-rational approaches, including metabolic engineering, adaptive laboratory evolution, physical & chemical mutagenesis, high-throughput screening, Rhodosporidium is expected to be engineered to utilize lignocellulosic biomass, glycerol and methanol to produce and export fatty acid derivatives (highlighted in blue), terpenoids (highlighted in light orange). Key genes involved in fatty acid derivatives are highlighted in green and red (identified and characterized well in literature). Abbreviations: GA-3-P, glyceraldehyde 3-phosphate; DHAP, dihydroxyacetone phosphate; G-3-P, glycerol-3-phosphate; LPA, lysophosphatidic acid; PA, phosphatidic acid; DAG, diacylglycerol; TAG, triacylglycerol; FFA, free fatty acid; OAA, oxaloacetate; IPP, isopentenyl diphosphate; DMAPP, dimethylallyl diphosphate.